Stocks
Amicus Therapeutics (FOLD) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -202.9 | -199.6 | -92.1 | 29.4 | 53.8 | 53.8 | |
| Changes by years, y/y, % | -17% | -2% | -54% | -132% | +83% | |||
Amicus Therapeutics. EBITDA US GAAP, bln rub
Amicus Therapeutics. EBITDA US GAAP, changes, %
Amicus Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Amicus Therapeutics (FOLD) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 21.9 | -4.75 | -5.76 | 47.9 | 16.5 | 53.8 | |
| Changes by years, y/y, % | -232% | -84% | -139% | +121% | -25% | |||
| Changes by quarters, q/q, % | +1% | -122% | +21% | -930% | -66% | |||
